Guihao Ke

1.1k total citations · 1 hit paper
33 papers, 646 citations indexed

About

Guihao Ke is a scholar working on Obstetrics and Gynecology, Surgery and Oncology. According to data from OpenAlex, Guihao Ke has authored 33 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Obstetrics and Gynecology, 12 papers in Surgery and 10 papers in Oncology. Recurrent topics in Guihao Ke's work include Endometrial and Cervical Cancer Treatments (19 papers), Colorectal and Anal Carcinomas (9 papers) and Cervical Cancer and HPV Research (7 papers). Guihao Ke is often cited by papers focused on Endometrial and Cervical Cancer Treatments (19 papers), Colorectal and Anal Carcinomas (9 papers) and Cervical Cancer and HPV Research (7 papers). Guihao Ke collaborates with scholars based in China, United States and Poland. Guihao Ke's co-authors include Xiaohua Wu, Hao Wen, Xiaohua Wu, Yuqi Zhou, Umesh Mahantshetty, Takafumi Toita, Jyoti Mayadev, R. Tarnawski, Jun Zhu and Jin Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Guihao Ke

29 papers receiving 632 citations

Hit Papers

Global challenges of radiotherapy for the treatment of lo... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guihao Ke China 14 256 253 169 152 122 33 646
Denise Uyar United States 16 138 0.5× 257 1.0× 126 0.7× 252 1.7× 60 0.5× 43 664
Katsumi Kozasa Japan 18 253 1.0× 144 0.6× 116 0.7× 427 2.8× 115 0.9× 30 798
Eriko Yokoi Japan 16 172 0.7× 104 0.4× 101 0.6× 329 2.2× 89 0.7× 24 588
Adela Poitevin Mexico 8 136 0.5× 94 0.4× 77 0.5× 153 1.0× 79 0.6× 11 406
Jaime Coronel Mexico 13 191 0.7× 194 0.8× 51 0.3× 96 0.6× 119 1.0× 22 465
Albert J. Bonebrake United States 14 234 0.9× 106 0.4× 49 0.3× 245 1.6× 70 0.6× 23 531
Špela Smrkolj Slovenia 12 109 0.4× 173 0.7× 107 0.6× 123 0.8× 82 0.7× 44 421
Maria-Pilar Barretina-Ginesta Spain 10 198 0.8× 68 0.3× 63 0.4× 243 1.6× 37 0.3× 35 511
Joerg Schwarz Germany 11 140 0.5× 111 0.4× 109 0.6× 124 0.8× 190 1.6× 13 592
Naoko Komura Japan 16 97 0.4× 106 0.4× 93 0.6× 344 2.3× 31 0.3× 35 560

Countries citing papers authored by Guihao Ke

Since Specialization
Citations

This map shows the geographic impact of Guihao Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guihao Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guihao Ke more than expected).

Fields of papers citing papers by Guihao Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guihao Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guihao Ke. The network helps show where Guihao Ke may publish in the future.

Co-authorship network of co-authors of Guihao Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Guihao Ke. A scholar is included among the top collaborators of Guihao Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guihao Ke. Guihao Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Chi, Yong Wu, Ying Wu, et al.. (2025). The effectiveness of anti-PD-L1 treatment and the underlying regulatory mechanism in ovarian clear cell carcinoma. International Immunopharmacology. 164. 115344–115344.
2.
Yu, Min, et al.. (2025). Overexpressed CD24 and CD47 Indicate a Worse Prognosis in Cervical Cancer. Cancer Medicine. 14(23). e71443–e71443.
3.
5.
Wang, Tingting, Xi Cheng, Guihao Ke, et al.. (2023). Efficacy and safety of apatinib in patients with recurrent uterine malignancy: a prospective, single-center, single-arm, phase 2 study. Annals of Translational Medicine. 11(2). 106–106. 4 indexed citations
6.
Jiang, Long, et al.. (2022). Prognostic Effect of Primary Recurrence Patterns in Squamous Cervical Carcinoma After Radical Surgery. Frontiers in Oncology. 12. 782030–782030. 3 indexed citations
7.
Mayadev, Jyoti, et al.. (2022). Global challenges of radiotherapy for the treatment of locally advanced cervical cancer. International Journal of Gynecological Cancer. 32(3). 436–445. 109 indexed citations breakdown →
8.
Zhu, Jun, Chunyan Song, Zhong Zheng, et al.. (2021). Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial. Frontiers in Oncology. 11. 720343–720343. 13 indexed citations
9.
Zhao, Haiyun, Fei Xu, Jingyi Cheng, et al.. (2021). BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair. Oncogene. 40(15). 2711–2724. 48 indexed citations
11.
Zhu, Jun, Lina Yin, Qifeng Wang, Xiaohua Wu, & Guihao Ke. (2020). Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience. International Journal of Clinical Oncology. 25(12). 2144–2150. 2 indexed citations
12.
Guo, Qinhao, Jun Zhu, Yong Wu, et al.. (2020). Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single‐center analysis of 3,732 patients. Annals of Translational Medicine. 8(7). 485–485. 26 indexed citations
13.
Zhu, Jun, et al.. (2020). The clinical and prognostic implication of deep stromal invasion in cervical cancer patients undergoing radical hysterectomy. Journal of Cancer. 11(24). 7368–7377. 15 indexed citations
14.
Jiang, Wei, et al.. (2019). Targeting of β-Catenin Reverses Radioresistance of Cervical Cancer with the PIK3CA -E545K Mutation. Molecular Cancer Therapeutics. 19(2). 337–347. 13 indexed citations
15.
Yin, Lina, et al.. (2019). Ovarian transposition before radiotherapy in cervical cancer patients: functional outcome and the adequate dose constraint. Radiation Oncology. 14(1). 100–100. 26 indexed citations
16.
Li, Xiaoqi, Hao Wen, Xiaojun Chen, et al.. (2016). The Survival Rate and Surgical Morbidity of Abdominal Radical Trachelectomy Versus Abdominal Radical Hysterectomy for Stage IB1 Cervical Cancer. Annals of Surgical Oncology. 23(9). 2953–2958. 23 indexed citations
17.
Li, Jiajia, Guihao Ke, Libing Xiang, et al.. (2015). Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population. Gynecologic Oncology. 137(2). 274–279. 8 indexed citations
18.
Ke, Guihao, Linhui Liang, Jinming Yang, et al.. (2012). MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene. 32(25). 3019–3027. 110 indexed citations
19.
Han, Duo, Xiaohua Wu, Jin Li, & Guihao Ke. (2011). Postoperative Chylous Ascites in Patients With Gynecologic Malignancies. International Journal of Gynecological Cancer. 22(2). 186–190. 28 indexed citations
20.
Li, Jin, Ziting Li, Huaying Wang, et al.. (2011). Radical abdominal trachelectomy for cervical malignancies: Surgical, oncological and fertility outcomes in 62 patients. Gynecologic Oncology. 121(3). 565–570. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026